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Polyphosphoinositide hydrolysis was studied in membranes prepared from a human T cell leukemia line, 
JURKAT, prelabeled with myo-[2-3H]inositol. The formation of inositol bis- and trisphosphates was stimu- 
lated in a buffer with 110 nM free Ca 2+ with a nonhydrolyzable GTP analogue, GTP~,S, and NaF plus 
AIC13 in a time- and concentration-dependent ma ner. GTP~,S and NaF-A1CI3 had no significant effect on 
the inositol monophosphate level. AICI3 enhanced the NaF-stimulated release of inositol polyphosphates. 
Optimum concentrations of NaF and AICI3 produced 1.5-fold more inositol polyphosphates than that pro- 
duced by optimum concentration f GTP~,S. OKT3 monoclonal ntibody, an antibody against he T-cell 
receptor complex, did not stimulate the inositol polyphosphate formation by JURKAT membranes ven 
in the presence of GTP, although the antibody at the concentrations u ed markedly stimulated the hydro- 
lysis of polyphosphoinositides in intact JURKAT cells. 
Inositol trisphosphate; Phosphatidylinositol bisphosphate; GTP-binding protein; Guanine nucleotide; Fluoroaluminate; 
T-cell receptor 
1. INTRODUCTION 
Stimulation of a human T cell leukemia line, 
JURKAT, by phytohemagglutinin and con- 
canavalin A initiates rapid hydrolysis of 
Ptdlns(4,5)P2, formation of inositol phosphates, 
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bisphosphate; Ptdlns4P, phosphatidylinositol 4-phos- 
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and labeling of phosphatidic acid with 
[32p]phosphate [1-3]. An increase in [CaZ+]i ac- 
companies the hydrolysis of Ptdlns(4,5)Pz [2,4]. 
At least one receptor, or possibly the only receptor 
[4,5], participating in the lectin-induced transmem- 
brane signaling is the T-cell antigen receptor com- 
posed of the clonotypic oe/fl chain heterodimer (Ti) 
and its associated, monomorphic molecules, three 
CD3 subunits and CD3-~" subunits [6]. Thus, 
monoclonal antibodies directed against either Ti or 
CD3 induce the increase in [CaZ+]i and the 
hydrolysis of Ptdlns(4,5)P2 in JURKAT [4,7-9]. 
These results indicate that the activation of T lym- 
phocytes by antigen presenting cells and target cells 
induces the hydrolysis of Ptdlns(4,5)Pz and subse- 
quent increase in [Ca2+]i and activation of protein 
kinase C. 
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Recent studies in hepatocytes [10], blowfly 
salivary glands [11], cloned rat pituitary cells 
(GH3) [12,13], WRK1 cells [14], and HL-60 cells 
[15] have successfully demonstrated the receptor- 
stimulated hydrolysis of Ptdlns(4,5)P2 in cell-free 
systems. These studies have shown that a guanine 
nucleotide-binding regulatory protein(s) (G- 
protein) is involved in the coupling of the various 
receptors for Ca2+-mobilizing agonists to the 
hydrolysis of Ptdlns(4,5)P2 and Ptdlns4P. Ti-ce 
and /3 chains and CD3-8 and e chains in the 
Ti/CD3 complex have been cloned and sequenced 
[16-18]. Therefore, it is interesting to know how 
the Ti/CD3 complex participates in the hydrolysis 
of PtdIns(4,5)P2. The present study has been 
undertaken to characterize the polyphosphoino- 
sitide phospholipase C in JURKAT membranes 
with the hope of elucidating the mechanism of ac- 
tivation of phospholipase C by the monoclonal n- 
tibody against CD3. 
2. MATERIALS AND METHODS 
2.1. Materials 
OKT3 monoclonal antibody was prepared from 
culture supernatant of the OKT3 hybridoma, ob- 
tained from the American Type Culture Collec- 
tion, by protein A-Sepharose CL-4B (Pharmacia) 
chromatography, myo-[2-3H]Inositol (2.6 Ci/ 
mmol) was prepared by reduction of scyllo-inosose 
(Sigma) with NaB3H4 (10.3 Ci/mmol, Amers- 
ham), followed by extensive purification by paper 
chromatography. Commercial sources of chemi- 
cals were as follows: GTPTS, Boehringer Mann- 
heim; GTP, Sigma; AGI-X8 (200-400 mesh, 
formate form), Bio-Rad. 
2.2. Cell culture and membrane preparation 
JURKAT-FHCRC cells were cultured in 
Iscove's modified Dulbecco's medium (Gibco) 
supplemented with 5°70 heat-inactivated (56°C for 
30 min) fetal calf serum, 2 mM glutamine, 1mM 
sodium pyruvate, 50 U/ml penicillin, and 
50/~g/ml streptomycin [19]. The cells were labeled 
for 2 days in the same medium with myo-[2-3H] - 
inositol, which was added at 10/~Ci/ml unless 
otherwise stated. The labeled cells were washed 
twice with Tris-buffered saline without Ca 2÷ and 
Mg 2÷, and suspended at a concentration f 2 x 10 7 
cells/ml in a homogenization medium composed 
of 10 mM Hepes at pH 7.4, 110 mM KC1, 1 mM 
EGTA, 10mM LiCI, lmM ATP, and 5mM 
MgC12. Cells were disrupted at 4°C by N2 cavita- 
tion with Yeda press treatment. N2 pressure was 
applied for 20 min at 800 lb/inch 2 with constant 
stirring. The homogenate was centrifuged at 670 × 
g for 10 min at 4°C. The pellet was discarded and 
the supernatant was subjected to a second cen- 
trifugation at 2 × 105 x g for 30 min at 4°C. The 
final pellet was resuspended ata concentration f
1-2 mg protein/ml in the homogenization medium 
and used immediately. This preparation is 
designated as JURKAT membranes. Protein was 
measured by a modification of the method of 
Lowry et al. [20]. 
2.3. Assay for the formation of inositol 
phosphates by JURKAT membranes and 
lipid analysis 
Membranes from 8-17 x 105 JURKAT cells in 
50/~1 of the homogenization medium were mixed 
with 150/A of an incubation medium (10 mM 
Hepes at pH 7.4, 1 mM EGTA, 10 mM LiC1, 
5 mM MgCI2, and 0.8 mM CaC12) which con- 
tained guanine nucleotides, NaF, AICI3, or OKT3 
monoclonal antibody as indicated. A fluorimetric 
determination by the use of quin2 indicates that 
the mixture contained 110 nM free Ca 2÷. The mix- 
ture was incubated at 37°C for 5 min or the in- 
dicated time. Reactions were terminated by 
addition of 0.75 ml chloroform/methanol (1:2, 
v/v). After phase separation by adding 0.25 ml 
each of chloroform and water, the upper phase 
was used to determine InsP1, InsP2, and InsP3 by 
chromatography on AG1-X8 (formate form) col- 
umns [2,21,22]. When lipids were analyzed, insolu- 
ble residues on the first extraction were 
re-extracted with 1 ml chloroform/methanol/ 
conc. HC1 (200: 100: 1, v/v). The second extract 
was partitioned into two phases by adding 0.2 ml 
of 0.1 N HC1. The first and second lower phases 
were combined and used to determine Ptdlns, 
Ptdlns4P, and Ptdlns(4,5)P2 by thin-layer chroma- 
tography on precoated silica gel plates (LK5D; 
Whatman), which had been impregnated with 1 o70 
potassium oxalate/2 mM EDTA [2]. Chloroform/ 
methanol/4 M aqueous ammonia (9: 7 : 2, v/v) was 
used as developing solvent. 
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3. RESULTS AND DISCUSSION 
A polyphosphoinositide phospholipase C con- 
trolled by a G-protein can be most easily 
demonstrated by activating the G-protein with 
either GTPTS, a nonhydrolyzable GTP analogue, 
or NaF plus AICl3 [10,12,23,24]. It is known that 
Al 3+ in the presence of F -  modulates the activity 
of G-proteins, Ns, Ni, and transducin. The active 
principle is thought o be AIFZ [23,25], which ac- 
tivates the a,-subunits GDP of these proteins by 
mimicking the role of the 7-phosphate of GTP in 
its binding site [26]. 
Fig.1 shows the time course of formation of 
[3H]inositol phosphates by JURKAT membranes, 
prepared from myo-[2-3Hlinositol-labeled cells, in 
a buffer with 110 nM free Ca 2+. The formation of 
InsP2 and InsP3 was stimulated by GTPyS 
(100/~M) and, to a greater extent, NaF (5 mM) 
plus AICI3 (10/~M). The accumulation of InsP2 
was more prominent han that of InsPa. GTPTS 
and NaF-AICI3 had no significant effect on the 
InsP1 level. The relative proportions of 
[3H]PtdIns, [3H]PtdIns4P, and [3H]PtdIns(4,5)P2 
in JURKAT membranes were 95.8 +_ 4.9, 2.3 _+ 
0.2, and 1.9 +_ 0.0°7o of total inositol lipids, respec- 
tively (means +_ SE of 3 determinations). The 
highest levels of accumulated InsP2 and InsP3 in 
fig. 1 correspond to 62.507o f PtdIns4P and 47.1 07o 
of PtdIns(4,5)P2 present in JURKAT membranes 
at time 0. Small and transient changes in PtdIns4P 
and PtdIns(4,5)P2 contents were observed uring 
nl I I I 
Time ( ra in  ) 
15 min incubation after GTPTS and NaF-AICI3 
addition, suggesting the continual replenishment 
of PtdIns4P and PtdIns(4,5)P2 by phosphorylating 
reactions in the membranes. 
Fig.2 shows the effect of NaF concentration on 
InsP2 and InsP3 formation by JURKAT mem- 
branes. Increasing the NaF concentration en- 
hanced the accumulation of InsP2 and that of 
InsP3 with different dose-response curves. How- 
ever, plotting the sum of InsP2 and InsP3 vs 
NaF concentration gives the usual dose-response 
curve (fig.2), which may suggest hat at different 
NaF concentrations there is either a difference in 
the rates of InsP3 hydrolysis to InsP2 or a dif- 
ference in the preference by the polyphosphoino- 
sitide phospholipase C for PtdIns4P and 
PtdIns(4,5)P2. Whichever the reason is, the results 
shown in figs 1 and 2 indicate that the activation 
of the polyphosphoinositide phospholipase C in 
JURKAT membranes can be most appropriately 
~ta.., _ . L  
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Fig.1. Time course of GTPTS- and AIFZ-induced 
formation of inositol phosphates by JURKAT 
membranes. Membranes (97/zg protein/assay) from 
JURKAT cells labeled with 1/~Ci/ml of myo- 
[2)H]inositol were incubated at 37°C for the indicated 
time in the absence (©) or presence of 100/~M GTPTS 
(R) or 5 mM NaF plus 10/~M AICl3 (o). The formation 
of inositol phosphates (InsPl, InsP2, and InsP3) was 
analyzed. Values are means _+ SE of 3 determinations. 
Fig.2. Effect o f  NaF concentration on inositol 
polyphosphate formation by JURKAT membranes. 
myo-[2-3HlInositol-prelabeled JURKAT membranes 
(57/zg protein/assay) were incubated at 37°C for 5 min 
in the presence of the indicated concentration of NaF. 
The formation of inositol phosphates (InsPl, InsP2, and 
InsP3) was assayed. (Q) InsP3, (&) InsP2, (o) InsP3 and 
InsP2 combined. Values are means + SE of 4 
determinations. 
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expressed by the sum of InsP2 and InsP3 formed 
during the incubation. 
The NaF-induced inositol polyphosphate forma- 
tion by JURKAT membranes was enhanced by 
AICI3 (fig.3). In the presence of 5 mM NaF, max- 
imal enhancement was observed at 50/zM AICI3, 
which alone had no effect on the inositol 
polyphosphate formation. It is highly probable 
that some AI 3+ is already present in the incubation 
mixtures without addition of A1CI~. Therefore, the 
results shown in fig.3 support the conclusion that 
A1Fg is the active principle responsible for the 
NaF-induced activation of phospholipase C in 
JURKAT membranes. 
Fig.4 shows the effect of GTPTS concentration 
on the inositol polyphosphate formation by 
JURKAT membranes. The half-maximal dose of 
GTPyS on inositol polyphosphate formation in 
JURKAT membranes is 5-10/zM. In JURKAT 
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Fig.3. Enhancement by AICI3 of NaF-induced inositol 
polyphosphate formation by JURKAT membranes. 
myo-[2-3H]Inositol-prelabeled JURKAT membranes 
(54/zg protein/assay) were incubated at 37°C for 5 min 
without (o) or with (t) 5 mM NaF in the presence of 
the indicated concentration of A1C13. The formation of 
inositol phosphates (InsP1, InsP2, and InsP3) was 
analyzed. Results are expressed as the sum of InsP2 and 
InsP3. Values are means ___ SE of 4 determinations. 
membranes, optimum stimulation with NaF plus 
AICI3 always released a larger amount of inositol 
polyphosphates a compared with that formed by 
optimum stimulation with GTP'rS. This can be 
found by comparing the results in figs 3 and 4, 
which were obtained by the use of the same 
preparation of JURKAT membranes. GTP had 
only a limited positive effect on inositol 
polyphosphate formation even at 250/zM (fig.4). 
Fig.5 shows the results of a study on the effect 
of OKT3 monoclonal antibody, an antibody 
against CD3, on the formation of inositol 
polyphosphates by JURKAT membranes. OKT3 
antibody did not stimulate inositol polyphosphate 
formation by JURKAT membranes even in the 
presence of 100FM GTP or 1-10/zM GTPTS. 
OKT3 antibody at the concentrations used in this 
experiment markedly stimulated JURKAT cells to 
produce inositol phosphates in the presence of Li ÷ 
(fig.5), which is a measure of polyphosphoino- 
sitide phospholipase C activation in intact cells 
[!,2,8,271. 
At present, we are not able to find the reason for 
the lack of stimulation by OKT3 antibody of 
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Fig.4. Effects of different concentrations of guanine 
nucleotides on inositol polyphosphate formation by 
JURKAT membranes, myo-[2)H]Inositol-prelabeled 
JURKAT membranes (54/zg protein/assay) were 
incubated at 37°C for 5 min in the presence of the 
indicated concentrations of GTP (e) and GTPyS (m). 
The formation of inositol phosphates (InsP1, InsP2, 
InsP3) was analyzed. Results are expressed as the sum of 
InsP2 and InsP3. Values are means __ SE of 4 
determinations. 
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The present results indicate the presence in 
JURKAT membranes of a G-protein coupled to a 
polyphosphoinositide phospholipase C. However, 
it may be argued whether the G-protein is involved 
in the Ti /CD3 receptor-stimulated polyphos- 
phoinositide hydrolysis in JURKAT cells. Par- 
ticipation of a G-protein has been found in all 
cell-free systems which show receptor-dependent 
activation of the phospholipase C [10-15]. A re- 
cent study on the mitogen-stimulated activation of 
ornithine decarboxylase in human T lymphocytes 
has proved that GTP is essential for the cellular 
response by the rapid activation of the enzyme 
[29], which seems to be a secondary response 
following polyphosphoinositide hydrolysis and a 
rise in [Ca2+]i [30l. 
Fig.5. Effects of different concentrations of OKT3 
monoclonal antibody on inositol polyphosphate 
formation by JURKAT membranes and on inositol 
phosphate production by JURKAT cells. This figure 
contains results obtained in two different experiments. 
In one experiment, myo-[2-3H]inositol-prelabeled 
JURKAT membranes (83/zg protein/assay) were 
incubated at 37°C for 5 min in the presence of the 
indicated concentration of OKT3 monoclonal antibody 
without (o) or with either 100/zM GTP (e) or l/zM 
GTPTS (&). The formation of inositol phosphates 
(InsP~, InsP2, InsP3) was analyzed. Results are 
expressed as the sum of InsP2 and InsP3. Values are 
means +_ SE of 5 determinations. In the other 
experiment, JURKAT cells (3 × 105 cells/assay) labeled 
with 2/zCi/ml of myo-[2-3H]inositol were incubated at 
37°C for 5 min in the presence of the indicated 
concentration of OKT3 monoclonal antibody in 0.2 ml 
Dulbecco's phosphate-buffered saline containing 
10 mM LiC1. The accumulation of total inositol 
phosphates (the sum of InsPh InsP2, and InsP3) was 
determined as in [1,2,8]. Values (n) are means _+ SE of 
3 determinations. 
polyphosphoinositide phospholipase C in 
JURKAT membranes. Aggregation of Ti /CD3 
complexes i probably an essential step in inducing 
the activation of the complex following the binding 
of OKT3 antibody to the complex [28]. In this 
respect, OKT3 antibody is probably unique among 
the CaE+-mobilizing agonists used in demon- 
strating the receptor-coupled activation of poly- 
phosphoinositide phospholipase C in cell-free 
systems. 
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